Benzinga | Nov 11, 2020 09:08AM EST

ENDRA Life Sciences To Exhibit TAEUS System At The Liver Meeting Digital Experience Nov. 13-16 And Radiological Society Of North America Nov. 29-Dec. 5

Will Exhibit at the Liver Meeting and at the Radiological Society of North America Annual Meeting

ANN ARBOR, MI / ACCESSWIRE / November 11, 2020 / ENDRA Life Sciences Inc. (''ENDRA'') (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS(r)), is exhibiting its TAEUS(r) System at The Liver Meeting Digital Experience (TLMdX) organized by the American Association for the Study of Liver Disease (AASLD), Nov. 13-16, 2020, and at the Radiological Society of North America (RSNA) scientific assembly and annual meeting, Nov. 29-Dec. 5.

"Having a strong digital presence at virtual medical conferences is a key component of our commercialization and market adoption strategy for TAEUS(r), and we are pleased to exhibit at TLMdX and RSNA, two major global conferences. Our virtual interactive booth will allow attendees to experience the TAEUS(r) workflow and understand the meaningful benefits of our innovative solution to assess and combat NAFLD and NASH, as well as provide the opportunity to discuss the first clinical installations with our knowledgeable ENDRA team," said ENDRA's Chief Commercial Officer, Renaud Maloberti.

"With an expected participation of tens of thousands clinicians at the TLMdX and RSNA, these conferences are critically important for raising awareness of TAEUS(r)' capabilities and are complementary to our brand- and relationship-building efforts with the clinical community worldwide," continued Maloberti.

ENDRA's TAEUS(r) Fatty Liver Imaging Probe (FLIP) System is an easy-to-use, non-invasive and cost-effective way to assess liver fat at the point of care. Following the TAEUS(r) System's receipt of the CE Mark earlier this year, ENDRA has focused on executing key components of its European commercialization plan, including establishing clinical evaluation sites that use TAEUS(r) to measure and monitor liver fat. Simultaneously, ENDRA has also submitted a 510(k) application to the U.S. FDA for clearance of the TAEUS(r) FLIP.

ENDRA's virtual trade show booth is accessible on the Company's website or directly at www.endrataeus.com. Because ENDRA will maintain the virtual booth beyond the duration of these conferences, hepatologists, gastroenterologists, radiologists, and other clinicians will be able to get an immersive and informative look at TAEUS(r) and experience it for themselves at their convenience.